QDX Technologies is a Melbourne-based deep-tech company co-founded in 2023 by Associate Professor Giuseppe Barca, dedicated to accelerating drug discovery by integrating quantum-accurate molecular simulations and advanced AI methodologies. The company achieved the first quantum simulation of biological systems at a scale necessary to accurately model drug performance, utilizing the Frontier exascale supercomputer at Oak Ridge Leadership Computing Facility. QDX developed groundbreaking software capable of accurately predicting chemical reactions and physical properties of molecular systems comprising up to hundreds of thousands of atoms. Headquartered in Melbourne with operations in Singapore and Canberra, QDX collaborates with Oak Ridge National Laboratory, AMD, and biotechnology and pharmaceutical partners globally. Co-founder Giuseppe Barca received the 2024 ACM Gordon Bell Prize for groundbreaking quantum chemistry simulations for drug discovery.
Explore other quantum computing companies in similar categories or regions.
Information for Educational Purposes Only: All information about QDX is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of QDX's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.